Breaking News

Synerlab Acquires Lyofal

November 15, 2012

Gains lyophilization services

Synerlab, a French CMO, has acquired Lyofal, gaining access to the growing market of lyophilized dosage forms, and expanding its existing range of outsourcing services. Financial terms of the acquisition were not disclosed.
Lyofal’s core business is outsourcing lyophilization services, providing services from determining lyophilization parameters, formulation assistance, and improvement of existing cycles within R&D, to production of pilot and industrial scale for bulk products (APIs, plant or animal extracts), as well as vials (diagnostic use) or molded forms (haemostatic patches or medical devices).

Related Contract Manufacturing:

Related Packaging:

blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision